Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

breast cancer, estrogen receptor-negative breast cancer, estrogen receptor-positive breast cancer, her2-negative breast cancer, progesterone receptor-negative breast cancer, progesterone receptor-positive breast cancer, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiic breast cancer, interventional